Novel SARS-CoV-2 specific antibody and neutralization assays reveal wide range of humoral immune response during COVID-19

Development of antibody protection during SARS-CoV-2 infection is a pressing question for public health and for vaccine development. We developed highly sensitive SARS-CoV-2-specific antibody and neutralization assays. SARS-CoV-2 Spike protein or Nucleocapsid protein specific IgG antibodies at titer...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :medRxiv
Главные авторы: Dogan, Mikail, Kozhaya, Lina, Placek, Lindsey, Gunter, Courtney L., Yigit, Mesut, Hardy, Rachel, Plassmeyer, Matt, Coatney, Paige, Lillard, Kimberleigh, Bukhari, Zaheer, Kleinberg, Michael, Hayes, Chelsea, Arditi, Moshe, Klapper, Ellen, Merin, Noah, Liang, Bruce T, Gupta, Raavi, Alpan, Oral, Unutmaz, Derya
Формат: Artigo
Язык:Inglês
Опубликовано: Cold Spring Harbor Laboratory 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7359542/
https://ncbi.nlm.nih.gov/pubmed/32676617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.07.07.20148106
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы